ArticleAdvances in therapy2025

Matching-Adjusted Indirect Treatment Comparison of Tarlatamab Versus Comparator Therapies in England in Patients with Extensive-Stage Small Cell Lung Cancer Who Have Received Two or More Prior Lines of Therapy.

Rumbidzai Takundwa et al.PubMed ↗Publisher ↗

No numbers read from the abstract.